Hikma’s Latest Advair Setback Pushes It Closer To Rivals

Further CRL From FDA Is ‘Minor’; Cipla Filed ANDA In May

 
• By David Wallace
  
Runner
Hikma is still leading the race to get the second US generic Advair • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products